The FDA passes new legislation for user fees and right-to-try applications August 14, 2017 CenterWatch Staff
Galapagos announces phase IIa results with GLPG1690 in IPF patients August 11, 2017 CenterWatch Staff
Gilead announces FDA priority review designation for fixed-dose treatment of HIV August 11, 2017 CenterWatch Staff